Industry Analysis Reports | Health Care | Medical Devices

Thursday, 10 December 2020

Technology Trends On Artificial Intelligence (AI) in Drug Discovery Market Size, Share and Forecast

Artificial Intelligence (AI) in Drug Discovery Market Overview

AI drug discovery has proved itself as a vital part of the drugs industry. This technology is used for regulating drug innovation & progress costs and in decreasing the processing time. Fast adoption and other features will help the global AI in the drug discovery market to touch a 41% annual growth rate. AI method uses different algorithms for improving the drug designs, their molecular structures and classification of various forms of drugs. All of the above features are adding to the tally of the market and giving it a considerable push to reach new levels of success.

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of AI in drug discovery market 2020 @https://www.marketresearchfuture.com/sample_request/9393

According to Market Research Future (MRFR), the global AI in drug discovery market is poised to create a valuation of USD 2,015.1 MN by 2025, registering a massive 40.8% CAGR throughout the predicted years (2019 – 2025). Recent COVID 19 pandemic is projected to boost the size of the market. AI and machine learning integration in discovery and development applications are increasing to expedite drug development processes.

Also, substantial investments made into AI business are projected to boost the market growth. AI integration minimizes the risk of adverse reactions during trials, reduces the drug discovery timeframe, and, most importantly, reduces drug development costs. Machine learning and other AI tools have a vast potential to make the discovery of new pharmaceuticals faster, cheaper, and more productively. As a result, major pharma companies are increasingly using AI technology for drug discovery.

Moreover, rising numbers of start-ups operating in the AI spectrum drug discovery foster market growth. Simultaneously, increasing numbers of cross-industry partnerships formed to achieve improvements in drug development outcomes drive the growth of the market. On the other hand, high costs associated with AI integration are a major factor estimated to hamper the market growth. Also, the lack of adequate infrastructure in low economic countries obstructs the growth of the market.

Market Segments of the Artificial Intelligence (AI) in Drug Discovery Market

The global market for AI in drug discovery is segmented into three factors:

Product type: There are three types of products, namely software, hardware and services.

Technology-based: Technologies like machine learning, deep learning, natural language processing and querying method are some examples of technology.

Application-based: AI technology is used in candidate screening, preclinical testing, target identification and others.

End-Users: Contract research organisations (CROs), pharma and biotech industries and government research facilities are some of the end-users.

AI in Drug Discovery Market – Regional Analysis

North America dominates the global AI in drug discovery market. Market share attributes to the increasing prevalence of chronic diseases and high healthcare expenses. Moreover, the recent COVID 19 pandemic is estimated to increase the size of the regional market. Besides, factors such as the presence of growing numbers of big AI platform developers and a well-developed healthcare sector in the region allow rapid market growth.

Increasing adoption of top AI platforms, including Google AI, Microsoft Azure, and TensorFlow by major pharma companies in drug discovery processes, boost the regional market growth. Moreover, increasing demand for Artificial Intelligence technologies from key pharmaceutical companies such as AbbVie, Genentech, Eli Lilly and Company, and Amgen, among others, drive the growth of the market.

Europe stands second in the global AI in drug discovery market. Market growth is driven by the increasing R&D activities in the pharma sector and the high demand for AI solutions by drug development companies. Top pharma companies in the region form strategic partnerships with international AI service providers to expedite their drug discovery process, which, in turn, boosts the market growth. The UK, Germany, and France are the major growth contributors to the regional market.

Additionally, substantial R&D investments and increasing government funding in the development of AI technology foster regional market growth. Furthermore, the recent COVID 19 epidemic is estimated to increase the size of the regional market. Besides, strategic deals between the UK government and industry players are expected to increase AI research investments. The European AI in the drug discovery market is projected to create a substantial revenue pocket.

The Asia Pacific AI in drug discovery market is estimated to become the fastest-growing market. Factors such as the increasing demand for effective drug discovery solutions and rapidly growing pharmaceutical sectors in the region drive market growth. A number of start-ups in the region are working to integrate AI Drug discovery Market. It is predicted that the adoption of AI technologies in mainstream drug discovery protocols will take place in the future. With their increasing numbers of AI platform companies, countries like India and China contribute significantly to the regional market growth.

AI in Drug Discovery Market - Competitive Analysis

The global AI in drug discovery market appears fiercely competitive & fragmented due to the presence of numerous well-established players. To gain a larger competitive advantage in the market, these players incorporate strategic initiatives such as mergers & acquisitions, collaborations, technology launch, and expansion. Also, AI drug discovery companies make substantial investments to R&D and drive clinical studies.

Major Players:

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others.

Innovation/Industry/Related News:

June 01, 2020 ---- Syntekabio Inc. (South Korea), a bioinformatics venture firm and AI drug Development Company, announced the identification of a respiratory disease drug as a potential COVID19 therapeutics. The crystal structure of SARS-CoV-2’s 3CL protease (Mpro) is the main viral protease that plays a crucial role in viral gene expression and proliferation of the SARS-CoV-2 virus. As soon as this structural information became available, Syntekabio commenced AI screening using its proprietary AI platform DeepMatcherTM and supercomputer. The company screened 3,000 approved drugs and identified potential COVID-19 therapeutics.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

News 2020: Clinical Laboratory Test Market size, Report, Key Trends and Forecast

MRFR is the Leading Brand in The Research Company who Recently Published Global Clinical Laboratory Test Market Research Reports which includes Study of Growth Overview, Regional Analysis, Top Players, Major Drivers, Upcoming Trends and Foreseen to 2023.

Clinical Laboratory Test Market to Rise at 6.5% CAGR due to Growing Prevalence of Diseases

Clinical laboratory testing plays a major role in the healthcare sector, as it is used to diagnose diseases and help the patient mMarket Research Future (MRFR) has announced a new release on the global clinical laboratory test market. The report provides a detailed account of the market’s likely growth trajectory over the forecast period based on a study of the market’s historical growth and present conditions. Major segments and leading players in the global clinical laboratory test market are profiled in the report to provide an accurate report of the market’s inner workings. Key drivers and restraints affecting the global clinical laboratory test market are assessed in the report to provide readers with an accurate picture of the conditions favoring and hampering the market’s growth. According to the report, the global clinical laboratory test market is expected to exhibit a CAGR of 6.5% over the forecast period from 2017 to 2022, rising from a value of USD 206.7 billion in 2016 to USD 324.5 billion in 2022.

anage the disease. Clinical laboratories also play a major role in enhancing the chances of disease prevention by researching the behavior of various disease-causing organisms.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1649

The growing prevalence of diseases and the growing demand for in-vitro diagnostic tests are likely to be the major drivers for the global clinical laboratory test market. Various lifestyle and environmental factors have combined to drive the global prevalence of diseases, which has driven the demand for diagnostic and therapeutic services. The effectiveness of in-vitro diagnostics has driven the demand for the same in the healthcare sector, which is likely to remain a key driver for the global clinical laboratory test market over the forecast period.

The growing global population and increasing awareness among patients are also likely to be major drivers for the global clinical laboratory test market over the forecast period. On the other hand, strict government rules and regulations on testing quality and safety are likely to restrain the clinical laboratory test market’s growth over the coming years.

Competitive Landscape:

Leading players in the global clinical lab testing market include AURORA Diagnostics, LifeLabs Medical Laboratories, Sonic Healthcare, Quest Diagnostics, and Laboratory Corporation of America.

Segmentation Analysis:

The global clinical laboratory test market is segmented on the basis of lab type, test type, and region.

On the basis of laboratory type, the global clinical laboratory test market is segmented into hospital-based laboratories, central/independent laboratories, physician office laboratory (POL), and others.

On the basis of test, the market is segmented into complete blood count (CBC) and other routine blood tests, anatomic pathology, molecular tests, immunology tests, drug testing, and others.

Regional Analysis:

Geographically, the global clinical laboratory test market is segmented into North America, Europe, Asia Pacific, and rest of the world.

North America is the dominant regional market in the global clinical laboratory test market due to the widespread of clinical laboratories and the increasing desire to incorporate the latest innovations in the healthcare sector. Government support to medical research is reasonably high in this region, which is likely to remain the major driver for the clinical laboratory test market in the region over the forecast period. The growing prevalence of diseases in the region is also a major driver for the clinical laboratory test market in North America. The U.S. is the leading country-level market within North America and is expected to grow at a CAGR of 5.8% over the forecast period. Canada is expected to exhibit a slightly higher 6.3% CAGR over the forecast period.

Europe is expected to exhibit strong growth in the global clinical laboratory test market over the forecast period, at a 6.6% CAGR. The Europe market holds the second largest share in the global clinical laboratory test market and is likely to make significant contributions to the market over the forecast period due to the strong growth prospects of the healthcare sector in the region.

Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the growing awareness about clinical testing and the growing government support for improving the healthcare sector, especially in countries such as India and other southeast Asian countries.

Browse Complete 88 Pages Premium Research Report Enabled with 89 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/clinical-laboratory-test-market-1649

About Market Research Future:

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Hemophilia Treatment Drugs Market Shares Analysis, Key Development Strategies and Forecasts To 2023

Hemophilia Treatment Drugs Market Highlights

According to the latest report published by Market Research Future (MRFR), the global market for hemophilia is set to surge at a CAGR of 6.10% between 2018 and 2023. The market is expected to reach a valuation in excess of USD 16,000 Mn by the year 2023. Hemophilia is an inherited genetic blood disorder and holds a chronic status. People with hemophilia are likely to live with the condition throughout their life but the effects can be greatly reduced with the help of several hemophilia drug and therapeutics. The prevalence of hemophilia has increased across the globe in recent years. A higher level of awareness and high healthcare expenditure are two major factors that are driving the growth of haemophilia treatment market in the advanced countries in Americas and Europe.

Free Sample PDF@ https://www.marketresearchfuture.com/sample_request/5688

Growing used of recombinant products is also reflecting favourably on the global Hemophilia Treatment Drugs Market. Recombinant products are an alternative to plasma derived products and considered relatively safer. Hemophilia drugs that are manufactured using recombinant products have proteins that are derived from genetically engineered cell lines and thereby have minimum or zero risk of contaminations. Demand for recombinant products is expected to remain high during the forecast period. Such factors are expected to support the growth of the market as well. In addition, regions such as the Middle East & Africa (MEA) and Asia Pacific (APAC) are also presenting lucrative growth opportunities to market players.

Global Hemophilia Treatment Market: Segmental Analysis

MRFR’s report also includes an in-depth segmental analysis of the global market for haemophilia treatment based on type, treatment type, end user and region. On the basis of type, the market has been segmented into hemophilia A, hemophilia B, and hemophilia C. Of these, the hemophilia A segment will continue to hold the largest share of the market over 2023. The segment is projected to reach a valuation of more than USD 12,600 Mn towards the end of review period, reflecting a healthy CAGR. By treatment type, the market is segmented into plasma derived coagulation factor concentrate, recombinant coagulation factor concentrates, desmopressin, gene therapy and antifibrinolytic agents. The recombinant coagulation factor concentrates segment is expected to remain highly attractive during the assessment period. This is primarily owing to the high level of safety and efficacy offered by recombinant coagulation factor concentrates. In 2017, the segment stood at market valuation of USD 6,500 Mn. By end user, the market is segmented into hospitals & clinics, research organization and others. By the year 2023, the hospitals & clinics segment is expected to surpass a market valuation of USD 11,000, exhibiting an impressive CAGR of 6.53%.

Global Hemophilia Treatment Market: Regional Analysis

Based on regions, the hemophilia treatment market has been segmented into Europe, Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA). Currently, the Americas region holds the largest share of the global haemophilia treatment market and is likely to retain its dominant position in 2018 and beyond. North America in particular present significant growth opportunities to market owing to factors such as high healthcare expenditure and existence of an advanced healthcare system. Meanwhile, Europe has emerged as the second largest market for hemophilia treatment. Presence a large number prominent drug manufacture gives the Europe market an edge. The market in APAC is also expected to witness a healthy growth during the forecast period. Rapid growth of the healthcare sector and introduction of favourable policies are attracting market players towards the region.

Growth Hemophilia Treatment Market: Competitive Landscape

Bayer AG, Swedish Orphan Biovitrum AB, Pfizer Inc, Grifols International S.A, Octapharma, Baxter, F.Hoffmann-La Roche Ltd, CSL Behring, Novo Nordisk A/S, Kedrion, Sanofi and Shire are some of the key market participants mentioned in MRFR’s report.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312

Analysis on Conjugate vaccines market Demand | Size | Share | Trends | Global Demand

The global conjugate vaccines market is analyzed in detail in the latest market research report from Market Research Future (MRFR). The report studies the global conjugate vaccines market’s historical growth trajectory in order to provide pointers as to the major drivers and restraints affecting the market’s growth prospects and derive market growth markers that can indicate the market’s future growth trajectory over the forecast period from 2018 to 2027. The global conjugate vaccines market is expected to exhibit a robust 14.5% CAGR over the forecast period, according to MRFR.

Get Free Sample Copy !! https://www.marketresearchfuture.com/sample_request/1107

Conjugate vaccines are vaccines containing two antigens, one strong and one weak. The stronger antigen is generally made from proteins and is attached to a weaker polysaccharide antigen to form conjugate vaccines. Conjugate vaccines are used to counter diseases whose associated pathogens do not elicit a significant response from the human immune system on their own. As a result, a stronger antigen is attached to the weaker pathogen to make it more prominent and to elicit a stronger response from the immune system. The first conjugate vaccine was developed in response to the outbreak of meningitis, which still remains among the top targeted diseases in the conjugate vaccines market.

The growing government support for mass-scale vaccinations for disease eradication is likely to remain the prime driver for the global Conjugate vaccine market over the forecast period. Vaccination has taken on a key role in eliminating diseases such as meningitis, which can become a serious health problem given the right conditions. The growing support for further advancement in vaccine research and development is also likely to be a major driver for the global conjugate vaccines market over the forecast period. Considerable growth in vaccine development efforts from major market players is likely to be a major driver for the conjugate vaccines market over the forecast period.

Segmentation:

The global conjugate vaccine market is segmented on the basis of type, indication, end user, and region.

On the basis of type, the global conjugate vaccine market is segmented into haemophilus B, monovalent, multivalent, and others.

On the basis of indication, the conjugate vaccines market is segmented into influenza, pneumococcal, meningococcal, and others. Influenza dominates the global conjugate vaccines market with a 35% share, however, pneumococcal and meningococcal vaccines are also likely to take up a considerable share of the global conjugate vaccines market over the forecast period.

On the basis of end users, the market is segmented into pediatrics and adults.

Regional Analysis:

The global conjugate vaccines market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas dominates the global conjugate vaccines market due to the growing demand for wide-scale disease eradication through vaccines and the growing vaccine research environment in advanced countries such as the U.S. and Canada. The growing government support to vaccination and vaccine development in this region, along with the presence of a strong and advanced biotechnology sector in the region, is also likely to be a major driver for the conjugate vaccines market over the forecast period.

Europe follows the Americas region in terms of its share in the global conjugate vaccines market and is likely to remain in a leading position through the forecast period due to the growing awareness about vaccines in Europe and the growing demand for developing cost-efficient, effective formulations of vaccines. The strong presence of the medical biotechnology sector in the region is also likely to be a major driver for the conjugate vaccines market in Europe.

Asia Pacific follows Europe in the global conjugate vaccines market and is likely to hold a reasonable share in the global market over the forecast period due to the growing awareness about the importance of vaccination in countries such as China and India. The growing population of this region is likely to drive the conjugate vaccines market in Asia Pacific over the forecast period.

Competitive Analysis:

Leading players in the global conjugate vaccine market include GSK plc, Fablife, Sanofi Pasteur SA, Sinovac Biotech Ltd., GreenSignal Bio Pharma Limited, Bavarian Nordic, Taj Pharmaceuticals Limited, IDT Biologics, Pfizer, SutroVax Inc., and Merck & Co. Inc.

Industry Updates:

In March 2019, Pfizer initiated three phase III trials on its new 20-valent pneumococcal conjugate vaccine.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Latest Research On Healthcare Contract Manufacturing Market Regional Trends and Growth | MRFR

Healthcare Contract Manufacturing Market Scenario

The Global Healthcare Contract Manufacturing Market 2020, according to the MRFR analysis, is poised to mature at a 9.86% CAGR and is projected to reach USD 250.9 Billion by 2023.

Healthcare Contract Manufacturing Market Dynamics

The expiration of patents for major drugs and medical devices, competition and production and trade economics to favor contract manufacturing organization (CMO), mutual benefit to contract manufacturer and customer, and lean manufacturing and agility are some of the major drivers for the growth of contract manufacturing market for healthcare across the globe. A big patent cliff is occurring worldwide, especially in the pharmaceutical industry, in the healthcare sector.

Get Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5637

The patent cliff will lead to cheaper generic versions on the market , increasing demand for CMOs. Thus, the expiration of patent protection for major prescription drugs and the increasing demand for generic drugs are likely to enhance the growth of CMOs globally. In the other hand, the uncertainty of the supply chain and third party management problems and standardization and interoperability concerns are anticipated to impede business growth over the projected period.

Healthcare Contract Manufacturing Market Segmental Overview

The global market for healthcare contract manufacturing has been analyzed on the basis of service type, type, and lastly, industry.

The type-based segmentation of the global CMO market comprises of sterile and non-sterile.

The service-based segmentation of the global CMO market comprises pharmaceutical industry, medical device industry, and biopharmaceutical industry.

The industry-based segmentation of the global CMO market comprises medical device industry, pharmaceutical industry, and biopharmaceutical industry. Due to the rampant growth of the global medical device industry, the segment of medical devices led the market in 2016 by holding 43.7 per cent market revenue share.

Healthcare Contract Manufacturing Market Regional Summary

The global healthcare Contract Manufacturing Market, based on region, is segmented into the Americas, Europe , Asia-Pacific, and Middle East & Africa.

Driven by the presence of major pharmaceutical drug manufacturers, thriving pharmaceutical industry and leading medical device companies in the US and Canada, the Americas currently dominates the global healthcare contract manufacturing market.

Generic drug companies are the main customer base of contract manufacturers in Europe, contributing to the growth of the European CMO market. Important factors influencing European market growth include the presence of major manufacturers, Increase in the biopharmaceutical sector , government support for R&D, increased disposable income and the availability of technologically advanced products.

Asia-Pacific should record a comparatively higher CAGR over the forecast period. Countries like China and India continue to draw significant amounts of outsourcing work from developed countries due to factors such as large-scale production capacity , low labor costs , low cost of raw materials and low cost of manufacturing. Besides that, some of the key factors driving demand growth include rising healthcare spending, increasing manufacturers' R&D funding, and moreover multinational medical device manufacturers seeking opportunities in the region and expanding their presence in the region. The changing regulatory landscape of medical devices has been a concern for the region's contract-manufacturing healthcare market.

The Middle East & Africa contributes least to the global contract manufacturing market in the healthcare sector. The growing development of the medical sector in the Middle Eastern countries, increased R&D spending and the expansion of multinational companies in the region also influence market growth.

Healthcare Contract Manufacturing Market Competitive Dynamics

The eminent players in the global healthcare contract manufacturing market are Lonza AG, Boehringer Ingelheim, Grifols International, S.A, Catalant, Aesica Pharmaceuticals, AbbVie, Benchmark Electronics, Evonik Industries, Flex Ltd, Teva Pharmaceutical Industries, Forefront Medical Technologies, Hamilton Company, Sanmina Corporation, Mylan, Patheon, and Vetter Pharma International.

Read Complete Report With Covid 19 Impact on This @ https://www.marketresearchfuture.com/reports/healthcare-contract-manufacturing-market-5637

Industry Update

August 2020 - BioStem Technologies, Inc., a leading life sciences company specializing in the development and sale of perinatal tissue-based allografts for use in regenerative therapies, announced that its subsidiary, Blue Tech Industries, Inc. signed a Master Service Agreement with a new customer to manufacture the customer’s amniotic membrane platform for the next two years, in a deal estimated to be worth up to USD 2.4 million to BioStem.

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Covid19 impact on Acupuncture Market Shares Analysis, Key Development Strategies and Forecasts Till 2023

MarketResearchFuture.com (MRFR) in it’s Recently Announced study report asserts that the “Global Acupuncture Market” the report offer detailed insights about the Historical Trends and Current Scenario with Top Industry Players, Demand, Major Drivers and Industry Dynamics up to 2023.

The global Acupuncture Market is accruing rapidly mainly due to the augmenting demand for non-invasive therapies. The spreading awareness towards acupuncture and its benefits have led to an increase in the demand and the in the level of advancements in acupuncture therapy. These technical advancements such as the advent of laser devices and electroacupuncture are escalating the market on the global platform.

Acknowledging the enormous growth, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global Acupuncture market is poised to touch an exponential valuation by 2023, registering a phenomenal CAGR throughout the forecast period (2018-2023). In 2017, the size of the market had reached at USD 24551.6 MN.

Get Sample Free Report https://www.marketresearchfuture.com/sample_request/6139

Additionally, factors such as the increasing number of geriatric populaces who are prone to diseases such as joint or bone pain, arthritis, epilepsy, nerve damage, and depression, owing to low immunity levels or gene alteration. Moreover, the increasing prevalence of various chronic diseases & disorders, injuries, and others foster the growth of the market.

On the other hand, factors such as the lack of approved clinical support alongside the side-effects associated with acupuncture treatment are impeding the growth of the market. Nevertheless, factors such as the technological advancements expected to get transpired in the field will support the growth of the market, bringing about new acupuncture devices and refining the existing ones further.

Major Players:

Key players leading the global Acupuncture market include Schwa-medico GmbH, Wuxi Jiajian Medical Instruments Co., Ltd, 3B Scientific GmbH, Zepter International, SEIRIN Corporation, Cymedics GmbH & Co. KG, Asia-med GmbH, MKW Laser system GmbH, Qingdao Great Fortune Co., Ltd., and AcuMedic Ltd. among others.

Acupuncture Market – Segments

For ease of understanding, the market is segmented into four key dynamics: -

By Product & Services : Services (Traditional Chinese Medicine, Japanese Acupuncture, Korean Hand Acupuncture, Auricular & Scalp Acupuncture, Non-Insertion Acupuncture, Moxibustion, and others) and Products (Cupping & Needles, Suction Cups, Laser Needle, Rod Lasers, Laser Pens, Electro-Acupuncture Devices, and others.).

By Application: Pain Syndrome Illnesses and Gynecological Disorders among others.

By End-user: Wellness Center and Hospitals & Specialty Clinics among others.

By Regions: North America, Asia Pacific, Europe, and the Rest-of-the-World.

Global Acupuncture Market – Regional Analysis

The European region heading with the presence of a large number of players accounts for the dominating market in the global Acupuncture market. The region is expected to exhibit a phenomenal growth prospect throughout the review period. The increasing number of occurrences of chronic diseases alongside the growing preference for acupuncture therapies amongst the European population drives the growth of the regional market.

Furthermore, factors such as the escalating insurance coverage in nations like Austria, France, Spain, and others, by other private companies and government support for R&D activities, increase in geriatric population, and the increasing demand for Acupuncture therapies and devices add to the growth in the regional market. The European acupuncture market is expected to grow at a CAGR of 13.53 % over the forecast period.

The Acupuncture market in the Asia Pacific region is another lucrative market, globally. The market is primarily led by the growing inclination towards the alternative therapies and major markets in China and India which have emerged as the fastest growing market for acupuncture devices. Additionally, increasing healthcare expenditures and the prevalence of various common disorders are positively impacting the growth of the regional market.

Global Acupuncture Market – Competitive Analysis

Highly competitive, the Acupuncture market appears to be fragmented due to the presence of several key players who are making substantial investments in R&D activities to bring about innovations in the devices.

Manufacturers of acupuncture devices try to develop instruments that are user-friendly, convenient and can allow physicians to optimize the pain treatment efficiently, literally, for each patient. Caregivers try to offer uniquely refined treatments using advanced devices with controlled incremental expansion designs.

Industry/Innovation/Related News:

March 15, 2019 ---- Cala Health, Inc. (the US), a Wearable bioelectronics developer and medical technology company pioneering neuro peripheral therapy announced its collaboration with Massachusetts General Hospital to help build out its non-invasive nerve stimulation platform for chronic diseases.

Through the hospital’s intellectual property management arm, Cala has licensed neuromodulation technology developed in the lab of MGH’s Vitaly Napadow. Neuromodulation helps in neural mechanisms related to chronic pain and the brain’s reactions to different forms of stimulation, including acupuncture. The licensed tech covers both transcutaneous vagus nerve stimulation and respiratory-gated vagal afferent nerve stimulation.

March 27, 2019 ---- Researchers at the Changchun University of Traditional Chinese Medicine (China), published the outcomes of a clinical trial they conducted on the uses of acupuncture to alleviate test anxiety, a type of performance anxiety. The results demonstrate that acupuncture reduces pre-examination anxiety and reduces sleep disturbances.

Check Discount at https://www.marketresearchfuture.com/check-discount/6139

About Market Research Future:

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Wednesday, 9 December 2020

NEWS: Veterinary Pain Management Market (2020-2027)

Overview:

Market Research Future (MRFR) in their detailed report on the global Veterinary Pain Management Market expected to register a CAGR of 6.46% during the assessment period of 2020 to 2027, to reach USD 4,582.8 Million by 2027.

Veterinary pain management is a part of the animal care sector where various equipment and medicines are developed to ease the pains of pets and other animals. The market is witnessing significant growth due to the extensive research that is taking place in various countries to come up with best possible counter measures. Major factor that is favoring the market is the increasing per capita income that is ensuring growing pet adoption rate. Cost-effective veterinary treatment is also another factor that can provide substantial tailwind to the market. Relentless works done by PETA and WHO are also triggering market expansion. But it can witness some setbacks due to lack of awareness among the commoners regarding pet healthcare.

Segmentation:

MRFR, to aide their study and users has segmented the global veterinary pain management market by drug type, devices, route of administration, animal type, application, and end-user.

Based on the drug type, the veterinary pain management market is segmented into nonsteroidal anti-inflammatory drugs, opioids, local anesthetics, α2-adrenergic agonists, muscle relaxants, sedatives, and corticosteroids. Nonsteroidal anti-inflammatory drugs include etodolac, fentanyl, and meloxicam. Opioids comprises morphine, hydromorphone, codeine, and others. Local anesthetics consists bupivacaine, lidocaine, chloroprocaine, and others. α2-adrenergic agonists are further segmented into xylazine, medetomidine, and others. By devices, the market can be sub-segmented into laser therapy devices and electromagnetic therapy devices.

On the basis of the route of administration, the veterinary pain management market comprises oral, parenteral, and topical.

Based on the animal type, the veterinary pain management market can be segmented into companion animals, livestock, research animals, aquatic animals, zoo animals, and exotic animals.

Application-wise, the veterinary pain management market is segmented into joint pain, postoperative pain, and cancer.

Based on the end-user, the veterinary pain management market includes veterinary hospitals and clinics, research institutes and universities, and laboratories.

Regional Analysis:

MRFR segments the veterinary pain management market into four regions North America, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA).

North America is leading the charge with a wide-range of animal care products, and with special emphasis on animal health. The region also has stringent government regulations to eliminate malpractice. In addition, advanced technologies are sufficiently providing tailwind to latest innovation by enabling research and development sector with in-depth study. Factors such as these are playing pivotal in market growth. Countries such as Canada and the U.S. are expanding their market by exporting exporting surgical equipment and surgical suturing material across the world. Besides, veterinary hospitals are also increasing in numbers which is further fueling market growth.

Increasing pet ownership is the reason behind Europe’s growth as a market and it further benefiting from the tax benefits granted by governments. European countries like Germany, France, and the U.K, are witnessing expenditure rising high to boost the production of medical and surgical devices.

The APAC is also showing promising signs where countries such as India and China can contribute significantly to the market. Australia and Japan can also turn major contributors. China has the regional dominance, whereas, India can grow with the fastest CAGR during the forecast period.

Competitive Landscape:

Notable players of the veterinary pain management market are Dechra Pharmaceuticals, Zoetis, Ceva Santé Animale, Chanelle, Norbrook Laboratories, Bayer, Merck Animal Health, Elanco, Boehringer Ingelheim, Assisi Animal Health, and Vetoquinol.

In 2018, ACTIVet PRO LaserShower was launched. The product is perfect for larger animals such as horse. It is portable which makes it easier to handle while using it as a therapy on such bigger animals. Laser therapy in last few years have evolved as a good pain-killer and this product is expected to corroborate that belief.

Another medicine, Cerenia is proving to be effective against abdominal pain and nausea. It is increasing the chance of survival of parvo puppies by 40% which is quite exciting.

Read More @ https://www.marketresearchfuture.com/reports/veterinary-pain-management-market-5961
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Thursday, 10 December 2020

Technology Trends On Artificial Intelligence (AI) in Drug Discovery Market Size, Share and Forecast

News 2020: Clinical Laboratory Test Market size, Report, Key Trends and Forecast

Hemophilia Treatment Drugs Market Shares Analysis, Key Development Strategies and Forecasts To 2023

Analysis on Conjugate vaccines market Demand | Size | Share | Trends | Global Demand

Latest Research On Healthcare Contract Manufacturing Market Regional Trends and Growth | MRFR

Covid19 impact on Acupuncture Market Shares Analysis, Key Development Strategies and Forecasts Till 2023

Wednesday, 9 December 2020

NEWS: Veterinary Pain Management Market (2020-2027)

Blog Archive

Total Pageviews